GlassScriptPhysician profile
Sarah Gibbons
NPI 1841447810
$11,989.92
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,357 · 2020: $5,188 · 2021: $37.36 · 2022: $1,855 · 2023: $457 · 2024: $95.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $5,188.46 | 2020 | |
| Lilly USA, LLC | $4,368.37 | 2019-2024 | Emgality, Reyvow |
| Upsher-Smith Laboratories LLC | $1,969.60 | 2022-2023 | |
| Amgen INC. | $159.86 | 2023 | Aimovig |
| Advanced Accelerator Applications | $110.00 | 2019 | |
| Amneal Pharmaceuticals LLC | $79.39 | 2023-2024 | Zomig |
| Abbvie INC. | $75.04 | 2022 | |
| Allergan, INC. | $24.20 | 2019 | |
| Biogen, INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Gibbons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.